Literature DB >> 3922877

Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.

T Gallart, J Bladé, J Martínez-Quesada, J Sierra, C Rozman, J Vives.   

Abstract

A patient with multiple myeloma (MM), who initially presented with a predominant IgG lambda and a minor IgD lambda paraprotein pattern, is described. After chemotherapy, levels of the IgD lambda protein increased and the IgG lambda levels decreased. The following results were obtained when serum IgD was predominant. In the bone marrow, there were three plasma cell populations: a major one containing only delta chains, a minor one containing only gamma chains, and another minor one containing both delta and gamma chains. All these plasma cell populations contained lambda chains. Stimulation of circulating mononuclear cells with pokeweed mitogen (PWM) achieved differentiation of circulating B lymphocytes into plasma cells: 30% with only cytoplasmic delta lambda chains and 10% with only cytoplasmic gamma lambda chains. These IgG-containing plasma cells showed cytoplasmic reactivity with rabbit antiserum raised against monoclonal IgD which was shown to contain specificities recognizing both delta chains and idiotypic determinants present in both serum IgD lambda and IgG lambda. Circulating B lymphocytes were 'monoclonal': almost all expressed surface delta lambda chains, and a small proportion of them expressed both delta gamma and lambda chains. High levels of IgD were detected in the supernatants of all cultures, but high concentrations of IgG were only detected in those from PWM-stimulated cultures with very low levels of IgM and IgA. These findings suggest that plasma cells producing either IgD or IgG were derived from a common B-cell clone. Double paraproteinaemia exhibiting a shift in immunoglobulin production from IgG to IgD has not been previously described.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922877      PMCID: PMC1453593     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Statistical study on double paraproteinemias. Evidence for a common cellular origin of both myeloma globulins.

Authors:  J P Bouvet; J Feingold; R Oriol; P Liacopoulos
Journal:  Biomedicine       Date:  1975-11

2.  Monoclonal IgA and IgM in the serum of a single patient (SC). I. Sharing of individually specific determinants between IgA and IgM.

Authors:  Y Yagi; D Pressman
Journal:  J Immunol       Date:  1973-02       Impact factor: 5.422

3.  Similarities of the light chains and the variable regions of the heavy chains of the IgG2 lambda and IgA1 lambda myeloma proteins from a single patient.

Authors:  C Wolfenstein-Todel; E C Franklin; R A Rudders
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

4.  Alternating appearance of IgD and IgG myeloma protein during treatment.

Authors:  V A Oxelius
Journal:  Scand J Haematol       Date:  1971

Review 5.  Idiotypic immunoglobulin structures on blood lymphocytes in human plasma cell myeloma.

Authors:  G Holm; H Mellstedt; D Pettersson; R Biberfeld
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

6.  Direct measurement of antibody affinity distribution by hapten-inhibition enzyme immunoassay.

Authors:  A Nieto; A Gaya; M Jansa; C Moreno; J Vives
Journal:  Mol Immunol       Date:  1984-06       Impact factor: 4.407

7.  Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.

Authors:  J L Preud'Homme; D Hurez; F Danon; J C Brouet; M Seligmann
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

8.  The evolution of alpha heavy chain disease.

Authors:  J Guardia; J Rubies-Prat; M T Gallart; A Moragas; J M Martinez-Vazquez; R Bacardi; J Vilaseca
Journal:  Am J Med       Date:  1976-04       Impact factor: 4.965

9.  Plasma cell myeloma with D-myeloma protein (IgD myeloma).

Authors:  J L Fahey; P P Carbone; D S Rowe; R Bachmann
Journal:  Am J Med       Date:  1968-09       Impact factor: 4.965

10.  Development of monoclonal IgA and an apparent IgG in a patient with macroglobulinemia: sharing of individually specific antigenic determinants among IgM, IgA, and IgG.

Authors:  D S Fair; S Schaffer; R G Krueger
Journal:  J Immunol       Date:  1976-09       Impact factor: 5.422

View more
  6 in total

1.  Non-secreting multiple myeloma switches to IgD of lamda type: a case report and review of literature.

Authors:  Lili Gao; Qinlu Li; Jinsong Kang; Chunrui Li; Jianfeng Zhou
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.

Authors:  P Engel; J Inglés; O de la Calle; T Gallart
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

3.  Humoral immunoresponse of pigeons to Aspergillus fumigatus antigens.

Authors:  J Martinez-Quesada; A Nieto-Cadenazzi; J M Torres-Rodriguez
Journal:  Mycopathologia       Date:  1993-12       Impact factor: 2.574

4.  Anti-islet cell and anti-insulin antibody production by CD5+ and CD5- B lymphocytes in IDDM.

Authors:  A Muñoz; T Gallart; E F Usac; J Fernández-Alvarez; O Viñas; N Somoza; J Barceló; R Gomis
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

5.  A Rare Presentation of Biclonal Gammopathy in Multiple Myeloma with Simultaneous Extramedullary Involvement: A Case Report.

Authors:  Pragnan Kancharla; Eshan Patel; Kenneth Hennrick; Sherif Ibrahim; Mendel Goldfinger
Journal:  Case Rep Oncol       Date:  2019-07-16

6.  Orthologous Allergens and Diagnostic Utility of Major Allergen Alt a 1.

Authors:  Antonio Moreno; Fernando Pineda; Javier Alcover; David Rodríguez; Ricardo Palacios; Eduardo Martínez-Naves
Journal:  Allergy Asthma Immunol Res       Date:  2016-09       Impact factor: 5.764

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.